Raising the volume on real-world data and analytics
How COVID-19 could reshape clinical trials (Part I)
Estimates suggest more than 1,300 clinical trials have been negatively impacted by COVID-19. Peter Payne and Cynthia Senerchia of the Optum® Digital Research Network share how the pandemic has created new urgency for disruption and digitization of clinical trials in this Advisory Board Q&A.
RWD informs rare disease insights
The robust, end-to-end patient view provided by real-world data (RWD) fills the data divide of rare and genetic diseases. Learn how researchers can use RWD to decipher the history and clinical manifestations of rare and genetic diseases to power treatment development.
Machine Learning: How Life Sciences Companies are Using AI to Help Control Diabetes
What if we could improve and speed up the way scientists analyze and process data? What if AI could help us develop better predictive models for chronic disease? Experts share their real-world experiences doing just that in this on-demand webinar.
Explore the Optum Digital Research Network
The clinical trial paradigm is ripe for disruption. Everyone knows the challenges, the cost overruns, the deadlines missed, and the enormous risks in finding patients. See how the Optum Digital Research Network is changing the future of clinical trial processes.
FDA guidance on RWE signals new opportunities
With the FDA mandating the use of real-world evidence to support regulatory decision-making, there’s never been a better time for life sciences companies to invest in an enterprise-wide data strategy. Learn how Optum can help you develop greater data applications.
The great data transition: making the move from claims to EHR data
As talk of pandemics and population health trends fill our days, this white paper walks you through the ways claims data answers the hows, while EHR data gets to the whys. Learn how the immediacy of EHR data availability can be significantly impactful, particularly as the health care system works to address COVID-19.